- Home
- CDNS vs GSK Comparison
CDNS vs GSK Comparison
Compare CDNS & GSK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | CDNS | GSK |
|---|---|---|
| Founded | 1988 | 1715 |
| Country | United States | United Kingdom |
| Employees | N/A | N/A |
| Industry | Computer Software: Prepackaged Software | Biotechnology: Pharmaceutical Preparations |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 83.0B | 96.1B |
| IPO Year | 1994 | N/A |
Fundamental Metrics
Financial Performance| Metric | CDNS | GSK |
|---|---|---|
| Price | $299.55 | $59.07 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 15 | 2 |
| Target Price | ★ $369.47 | N/A |
| AVG Volume (30 Days) | 3.0M | ★ 6.2M |
| Earning Date | 05-20-2026 | 01-01-0001 |
| Dividend Yield | N/A | ★ 3.02% |
| EPS Growth | ★ 5.45 | N/A |
| EPS | ★ 4.06 | N/A |
| Revenue | ★ $5,296,759,000.00 | N/A |
| Revenue This Year | $14.41 | $6.75 |
| Revenue Next Year | $12.34 | $4.88 |
| P/E Ratio | $73.18 | ★ $32.75 |
| Revenue Growth | ★ 14.12 | N/A |
| 52 Week Low | $221.56 | $32.38 |
| 52 Week High | $376.35 | $61.70 |
Technical Indicators
Market Signals| Indicator | CDNS | GSK |
|---|---|---|
| Relative Strength Index (RSI) | 50.04 | 61.37 |
| Support Level | $269.68 | $47.89 |
| Resistance Level | $321.66 | $60.37 |
| Average True Range (ATR) | 12.45 | 0.83 |
| MACD | 1.72 | -0.36 |
| Stochastic Oscillator | 60.73 | 28.12 |
Price Performance
Historical ComparisonAbout CDNS Cadence Design Systems Inc.
Cadence Design Systems is a provider of electronic design automation software, intellectual property, and system design and analysis products. EDA software automates and aids in the chip design process, enhancing design accuracy, productivity, and complexity in a full-flow end-to-end solution. Cadence offers a portfolio of design IP, as well as system design and analysis products, which enables system-level analysis and verification solutions.
About GSK GSK plc (Each representing two)
In the pharmaceutical industry, GSK ranks as one of the largest firms by total sales. The company wields its might across several therapeutic classes, including respiratory, antiviral, and vaccines, and has been growing its presence in oncology and immunology, as well. GSK uses joint ventures to gain additional scale in certain markets like HIV.